Evaluation of THC-Related Neuropsychiatric Symptoms Among Adults Aged 50 Years and Older: A Systematic Review and Metaregression Analysis

This systematic review and metaregression analysis estimates the association between the delta-9-tetrahydrocannabinol (THC) dose of cannabinoid-based medicines and neuropsychiatric adverse events among adults aged 50 years and older.

Detalles Bibliográficos
Autores principales: Velayudhan, Latha, McGoohan, Katie Louise, Bhattacharyya, Sagnik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856542/
https://www.ncbi.nlm.nih.gov/pubmed/33528550
http://dx.doi.org/10.1001/jamanetworkopen.2020.35913
Descripción
Sumario:This systematic review and metaregression analysis estimates the association between the delta-9-tetrahydrocannabinol (THC) dose of cannabinoid-based medicines and neuropsychiatric adverse events among adults aged 50 years and older.

Ejemplares similares